Otilonium Bromide: High-Purity Antimuscarinic Agent for Neuroscience Research

Executive Summary: Otilonium Bromide is a solid antimuscarinic compound (C₂₉H₄₃BrN₂O₄, 563.57 g/mol) with verified ≥98% purity, targeting acetylcholine receptors (AChR) to exert antispasmodic effects on smooth muscle tissues (APExBIO product page). It demonstrates high solubility (≥28.18 mg/mL in DMSO, ≥55.8 mg/mL in water, and ≥91 mg/mL in ethanol) and is recommended for storage at -20°C for optimal stability. Otilonium Bromide is exclusively intended for research use, not for diagnostic or therapeutic applications. This agent is widely used in neuroscience and gastrointestinal motility disorder models to probe muscarinic receptor-mediated signaling and pharmacological response (related article). Its molecular mechanism and application parameters are supported by peer-reviewed evidence and product documentation (Vijayan & Gourinath, 2021).

Biological Rationale

Cholinergic signaling is central to smooth muscle regulation and neurotransmission in both central and peripheral nervous systems. Acetylcholine receptors, particularly muscarinic subtypes, mediate a range of physiological processes including gut motility and neurogenic smooth muscle contraction (Vijayan & Gourinath, 2021). Antimuscarinic agents like Otilonium Bromide are essential for dissecting these pathways due to their receptor selectivity and reversible inhibition. The compound's ability to modulate AChR activity enables detailed studies of synaptic transmission, receptor pharmacology, and disease models involving cholinergic dysfunction.

Mechanism of Action of Otilonium Bromide

Otilonium Bromide functions as a competitive antagonist at muscarinic acetylcholine receptors (AChRs), blocking acetylcholine-induced depolarization. This inhibition is dose-dependent, reversible, and specific to muscarinic subtypes involved in smooth muscle contraction. By preventing receptor activation, Otilonium Bromide reduces intracellular Ca²⁺ mobilization and downstream contractile responses. The net effect is a reduction in smooth muscle spasm, which is critical for modeling gastrointestinal motility disorders and for studying cholinergic modulation in neuronal and non-neuronal systems (APExBIO).

Evidence & Benchmarks

• Otilonium Bromide demonstrates ≥98% purity by HPLC, ensuring minimal interference in receptor binding assays (product page).
• The compound is soluble at ≥28.18 mg/mL in DMSO, ≥55.8 mg/mL in water, and ≥91 mg/mL in ethanol, measured at 25°C for 1 hour (APExBIO, source).
• Storage at -20°C preserves chemical stability for ≥12 months in solid form, as validated by batch stability data (scenario Q&A).
• Otilonium Bromide inhibits muscarinic AChR-mediated contractions in smooth muscle strips at concentrations from 1–100 μM, with IC₅₀ values typically in the low micromolar range (Vijayan & Gourinath, 2021).
• Used as a reference antagonist in translational models of gastrointestinal motility and neural circuit mapping (mechanistic review).

Applications, Limits & Misconceptions

Otilonium Bromide (SKU B1607) from APExBIO is widely adopted in:

• Neuroscience research for mapping cholinergic signaling pathways and receptor pharmacology (see also; this article provides a mechanistic update by presenting new quantitative solubility and stability data).
• Experimental models of smooth muscle contraction and gastrointestinal motility disorder.
• Cell-based assays to probe muscarinic receptor subtypes and downstream signaling events.
• Workflow optimization in cell viability, proliferation, and cytotoxicity assays (scenario Q&A; this extends previous practical advice with updated purity benchmarks).

Common Pitfalls or Misconceptions

• Otilonium Bromide does not inhibit nicotinic acetylcholine receptors; its specificity is limited to muscarinic subtypes.
• It is not intended for clinical or diagnostic use; research-only application is enforced by APExBIO's distribution policy.
• Long-term solution storage (>3 days) at room temperature may lead to compound degradation and reduced efficacy.
• It does not act as a broad-spectrum ion channel blocker.
• Assay interference may occur if used above recommended concentrations due to non-specific effects.

Workflow Integration & Parameters

Otilonium Bromide can be integrated into standard neuroscience and smooth muscle research workflows due to its robust solubility and batch consistency. For most cell-based and tissue assays, it is prepared as a 10–100 mM stock in DMSO or ethanol, then diluted to working concentrations (typically 1–100 μM) in physiological buffers. Solutions should be freshly prepared or stored at -20°C for short-term use (≤1 week) to maximize activity. High purity (≥98%) ensures reproducibility across experiments. APExBIO's supply chain provides batch-level documentation and technical support (Otilonium Bromide B1607 kit). For troubleshooting and scenario-driven guidance, researchers may consult detailed Q&As and bench protocols (assay optimization guide; this article clarifies batch stability and solubility thresholds beyond earlier discussions).

Conclusion & Outlook

Otilonium Bromide remains a gold-standard antimuscarinic agent for probing acetylcholine receptor-mediated processes in neuroscience and gastrointestinal research. Its high purity, defined solubility, and proven receptor specificity provide a reliable foundation for reproducible experimentation. Ongoing advances in cholinergic signaling research may further expand its applications, particularly in translational models of neurogastroenterology and pharmacological screening. For detailed product data and batch documentation, visit the APExBIO Otilonium Bromide page.